Latest filing published 15 Apr 2010 for IMMUNOSYN CORP, €1.7M.
Insider track record
No signal scores available.
Argyll Equities, LLC: trading record in brief
All filings by Argyll Equities, LLC on record concern Immunosyn Corp. Over a trading history stretching from 17 September 2008 to 14 December 2009, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 15 April 2010, reports a transaction of €1.7M in Immunosyn Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Argyll Equities, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 574,677 shares@ US$4.15Common StockSEC:0001437749-10-001098:0
- 2,950,000 shares0Common StockSEC:0001437749-10-001098:1
2 of 2 declarations